NO20063448L - Behandling av aromatase inhibitor terapi relatert-osteoporose - Google Patents
Behandling av aromatase inhibitor terapi relatert-osteoporoseInfo
- Publication number
- NO20063448L NO20063448L NO20063448A NO20063448A NO20063448L NO 20063448 L NO20063448 L NO 20063448L NO 20063448 A NO20063448 A NO 20063448A NO 20063448 A NO20063448 A NO 20063448A NO 20063448 L NO20063448 L NO 20063448L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- aromatase inhibitor
- inhibitor therapy
- related osteoporosis
- osteoporosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53603504P | 2004-01-13 | 2004-01-13 | |
PCT/US2005/000803 WO2005070434A2 (fr) | 2004-01-13 | 2005-01-11 | Traitement de l'osteoporose liee a la therapie par un inhibiteur de l'aromatase |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20063448L true NO20063448L (no) | 2006-09-29 |
Family
ID=34806981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20063448A NO20063448L (no) | 2004-01-13 | 2006-07-26 | Behandling av aromatase inhibitor terapi relatert-osteoporose |
Country Status (19)
Country | Link |
---|---|
US (1) | US20050272717A1 (fr) |
EP (1) | EP1703910A2 (fr) |
JP (1) | JP2007517899A (fr) |
KR (1) | KR20060127875A (fr) |
CN (1) | CN1929835A (fr) |
AR (1) | AR048394A1 (fr) |
AU (1) | AU2005206137A1 (fr) |
BR (1) | BRPI0506774A (fr) |
CA (1) | CA2552725A1 (fr) |
CR (1) | CR8495A (fr) |
EC (1) | ECSP066699A (fr) |
IL (1) | IL176628A0 (fr) |
NO (1) | NO20063448L (fr) |
PA (1) | PA8621401A1 (fr) |
RU (1) | RU2006123939A (fr) |
SG (1) | SG149081A1 (fr) |
TW (1) | TW200526206A (fr) |
UA (1) | UA84046C2 (fr) |
WO (1) | WO2005070434A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006114702A2 (fr) * | 2005-04-25 | 2006-11-02 | Pfizer Products Inc. | Compositions pharmaceutiques et methodes comprenant une combinaison d'un modulateur selectif du recepteur de l'oestrogene et d'un inhibiteur de l'aromatase |
WO2007024961A2 (fr) * | 2005-08-24 | 2007-03-01 | Wyeth | Preparations de bazedoxifene acetate |
AU2012275036B2 (en) * | 2005-08-24 | 2016-05-19 | Wyeth Llc | Bazedoxifene acetate formulations and manufacturing process thereof |
JP5449775B2 (ja) * | 2005-10-19 | 2014-03-19 | チャバフ ピーティーワイ エルティーディー | 乳癌の治療に使用されるアロマターゼ阻害薬による副作用の低減 |
WO2013182169A1 (fr) * | 2012-06-07 | 2013-12-12 | Zentiva, K. S. | Procédé de préparation d'une formulation d'acétate de bazédoxifène sans anti-oxydant et stable du point de vue polymorphe et chimique |
CN103860496A (zh) * | 2014-03-14 | 2014-06-18 | 王志刚 | 一种醋酸巴多昔芬分散片及其制备方法 |
US20160051565A1 (en) * | 2014-08-20 | 2016-02-25 | Professional Compounding Centers Of America (Pcca) | Transdermal Pharmaceutical Compositions Including Testosterone and an Aromatase Inhibitor |
CA2965372C (fr) | 2014-10-22 | 2023-09-05 | Havah Therapeutics Pty Ltd | Procede de reduction de densite mammaire monographique et/ou de risque de cancer du sein |
CN104546794A (zh) * | 2015-01-05 | 2015-04-29 | 万特制药(海南)有限公司 | 一种醋酸巴多昔芬胶囊及其制备方法 |
CN108472302A (zh) | 2015-10-22 | 2018-08-31 | 哈瓦赫治疗有限公司 | 降低乳房摄影乳腺密度和/或乳腺癌风险的方法 |
EP3976048A4 (fr) | 2019-06-03 | 2023-07-12 | Havah Therapeutics Pty Ltd | Formulations pharmaceutiques et systèmes pour l'administration d'un agent androgène et d'un inhibiteur de l'aromatase, et procédés d'utilisation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW303299B (fr) * | 1993-07-22 | 1997-04-21 | Lilly Co Eli | |
US5998402A (en) * | 1996-04-19 | 1999-12-07 | American Home Products Corporation | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
US6479535B1 (en) * | 1998-05-15 | 2002-11-12 | Wyeth | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
US6583170B1 (en) * | 1998-05-15 | 2003-06-24 | Wyeth | 2-Phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol and estrogen formulations |
AR029538A1 (es) * | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
EP1192945A3 (fr) * | 2000-09-21 | 2004-03-03 | Pfizer Products Inc. | Utilisation d'un agoniste/antagoniste estrogénique pour traiter l'ostéoarthrite |
US20040192598A1 (en) * | 2000-10-11 | 2004-09-30 | Laura Kragie | Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase |
EP1531807A4 (fr) * | 2002-06-13 | 2007-10-31 | Wyeth Corp | Schemas therapeutiques du bazedoxifene |
-
2005
- 2005-01-11 PA PA20058621401A patent/PA8621401A1/es unknown
- 2005-01-11 JP JP2006549520A patent/JP2007517899A/ja active Pending
- 2005-01-11 KR KR1020067013926A patent/KR20060127875A/ko not_active Application Discontinuation
- 2005-01-11 BR BRPI0506774-0A patent/BRPI0506774A/pt not_active IP Right Cessation
- 2005-01-11 CA CA002552725A patent/CA2552725A1/fr not_active Abandoned
- 2005-01-11 AR ARP050100089A patent/AR048394A1/es not_active Application Discontinuation
- 2005-01-11 CN CNA2005800081116A patent/CN1929835A/zh active Pending
- 2005-01-11 WO PCT/US2005/000803 patent/WO2005070434A2/fr active Application Filing
- 2005-01-11 AU AU2005206137A patent/AU2005206137A1/en not_active Abandoned
- 2005-01-11 TW TW094100730A patent/TW200526206A/zh unknown
- 2005-01-11 US US11/033,367 patent/US20050272717A1/en not_active Abandoned
- 2005-01-11 EP EP05705452A patent/EP1703910A2/fr not_active Withdrawn
- 2005-01-11 RU RU2006123939/14A patent/RU2006123939A/ru not_active Application Discontinuation
- 2005-01-11 SG SG200900062-1A patent/SG149081A1/en unknown
- 2005-01-11 UA UAA200607823A patent/UA84046C2/ru unknown
-
2006
- 2006-06-28 CR CR8495A patent/CR8495A/es not_active Application Discontinuation
- 2006-06-29 IL IL176628A patent/IL176628A0/en unknown
- 2006-07-13 EC EC2006006699A patent/ECSP066699A/es unknown
- 2006-07-26 NO NO20063448A patent/NO20063448L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SG149081A1 (en) | 2009-01-29 |
CN1929835A (zh) | 2007-03-14 |
TW200526206A (en) | 2005-08-16 |
CR8495A (es) | 2007-03-06 |
US20050272717A1 (en) | 2005-12-08 |
KR20060127875A (ko) | 2006-12-13 |
PA8621401A1 (es) | 2006-07-03 |
WO2005070434A2 (fr) | 2005-08-04 |
CA2552725A1 (fr) | 2005-08-04 |
BRPI0506774A (pt) | 2007-05-22 |
JP2007517899A (ja) | 2007-07-05 |
AR048394A1 (es) | 2006-04-26 |
ECSP066699A (es) | 2006-10-31 |
EP1703910A2 (fr) | 2006-09-27 |
WO2005070434A3 (fr) | 2006-06-08 |
AU2005206137A1 (en) | 2005-08-04 |
RU2006123939A (ru) | 2008-02-20 |
UA84046C2 (ru) | 2008-09-10 |
IL176628A0 (en) | 2006-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20063448L (no) | Behandling av aromatase inhibitor terapi relatert-osteoporose | |
AR058892A1 (es) | Metodos para tratar lupus cutaneo con el uso de compuestos de aminoisoindolina | |
NO20050985L (no) | 3-z-(1-(4-(n-((4-4metyl-piperazin-1-yl)-metylkarbonyl)- n-metyl-amino)-anilino)-1-fenyl-metylen)-6-metoksykarb onyl-2-indolinon-monoetansulfonat og anvendelse derav | |
BRPI0513866A (pt) | composição, micropartìculas, método para o tratamento da hipertensão pulmonar, e dispositivo de inalação | |
NO20054369L (no) | Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse | |
ATE516286T1 (de) | 5-(ä1,3,4üoxadiazol-2-yl)-1h-indazol und 5-(ä1,3, 4üthiadiazol-2-yl)-1h-indazol derivate als sgk- inhibitoren zur behandlung von diabetes | |
NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
NO20071926L (no) | Anvendelse av en mTOR-inhibitor i behandling av uterint leioyom. | |
NO20073396L (no) | Farmasoytiske kombinasjoner av en angiotensinreceptorantagonist og en NEP-inhibitor | |
NO20072654L (no) | Cancer behandling | |
NO20080217L (no) | B-celle reduksjon ved anvendelse av CD20-spesifikke bindingsmolekyler | |
NO20091926L (no) | Anti-Notch3-agonist-antistoffer og deres anvendelse ved behandlingen av Notch3-relaterte sykdommer | |
NO20080318L (no) | Anvendelse av enkelt dose av CD-20-spesifikke bindingsmolekyler | |
NO20063368L (no) | Alfa-aminoamid-derivater anvendelige ved behandling av lidelser i nedre urinveier | |
NO20071714L (no) | Fremgangsmateer for behandling av CD30 positive lymfomer | |
NO20014230L (no) | Fremgangsmåter og preparater som anvender (+) norcisaprid i kombinasjon med protonpumpeinhibitorer eller H2reseptorantagonister | |
EA200800755A1 (ru) | Ikk ингибиторы, предназначенные для лечения эндометриоза | |
NO20093039L (no) | Indolizineddiksyrederivater som CRTH2 antagonister | |
MXPA04006572A (es) | Terapia de combinacion antivirica. | |
EP1534278A4 (fr) | Inhibiteurs nitroses de la pompe a protons, compositions et procedes d'utilisation | |
ATE492283T1 (de) | Trialkylsilylbenzylaminocarboxyindole, indazole und indoline und ihre verwendung zur behandlung von cetp-vermittelten erkrankungen | |
DK1509492T3 (da) | Sedative hypnotiske midler med kort virkningsvarighed til anæstesi og sedation | |
NO20072190L (no) | Fremgangsmater og sammensetninger for behandling av kronisk lymfatisk leukemi | |
BR0008781A (pt) | Terapia combinada de inibidor de enzima conversora de angiotensina e antagonista de aldosterona epóxi-esteroidal para tratamento de doença cardiovascular | |
NO20033228D0 (no) | Anvendelse av IL-18 inhibitorer til behandling og/eller forhindring av hjertesykdom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |